7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC)
Key Takeaways
- A Trial of Labor After Cesarean (TOLAC) achieves a successful Vaginal Birth After Cesarean (VBAC) rate of 60% to 80%; successful VBAC is associated with lower maternal morbidity than elective repeat cesarean delivery (ERCD), whereas failed TOLAC requiring intrapartum cesarean carries the highest morbidity.
- Ideal TOLAC candidates have one prior low-transverse uterine incision, a clinically adequate pelvis, no history of uterine rupture or extensive transmural surgery, and continuous access to an obstetric provider and anesthesia capable of managing emergent delivery.
- Absolute contraindications to TOLAC include a prior classical or T-shaped uterine incision, prior extensive transmural uterine surgery entering the endometrial cavity (e.g., transmural myomectomy), prior uterine rupture, and standard contraindications to vaginal delivery (placenta previa, transverse lie).
- Prostaglandins (Misoprostol / PGE1 and Dinoprostone / PGE2) are strictly contraindicated for cervical ripening in patients with a scarred uterus due to a high risk of uterine rupture; mechanical methods (Foley/Cook balloon catheter) are the ripening modality of choice.
- The most consistent, earliest, and reliable clinical sign of acute uterine rupture during labor is an abnormal fetal heart rate pattern (prolonged deceleration, sudden severe bradycardia, or recurrent late decelerations), occurring in up to 70% to 90% of rupture events.
Clinical Foundations & Contemporary Practice Guidelines
Trial of Labor After Cesarean (TOLAC) refers to a planned attempt to labor by a patient who has previously undergone a cesarean delivery, with the clinical objective of achieving a Vaginal Birth After Cesarean (VBAC). According to national clinical consensus guidelines established by the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM), attempting a TOLAC is a safe, appropriate, and evidence-based option for the majority of patients with a prior low-transverse cesarean delivery.
In contemporary obstetric practice, the overall success rate for patients undergoing a TOLAC is between 60% and 80%. Understanding the balance of clinical risks and benefits across delivery pathways is essential for shared decision-making:
- Successful VBAC: Associated with the lowest overall maternal morbidity—less blood loss, lower transfusion rates, lower infection risk, shorter hospital stays, faster physical recovery, and avoidance of multiple hysterotomy scars that predispose to Placenta Accreta Spectrum (PAS) in future pregnancies.
- Elective Repeat Cesarean Delivery (ERCD): Carries predictable, intermediate surgical risks (blood loss, infection, visceral adhesions, surgical injury, and increased risk of abnormal placentation in subsequent pregnancies).
- Failed TOLAC (Unplanned Intrapartum Cesarean): Associated with the highest maternal morbidity, including higher rates of uterine rupture, operative complications, blood transfusions, endometritis, and maternal intensive care admissions.
+-------------------------------------------------------------------------------------------------------------------+
| MATERNAL MORBIDITY SPECTRUM IN CESAREAN MANAGEMENT |
+-------------------------------------------------------------------------------------------------------------------+
LOWEST MORBIDITY HIGHEST MORBIDITY
◄─────────────────────────────────────────────────────────────────────────────────────────────────────►
[ Successful VBAC ] [ Elective Repeat Cesarean (ERCD) ] [ Failed TOLAC ]
• Lowest blood loss • Intermediate blood loss • Highest blood loss
• Lowest infection rate • Planned surgical risks • Highest infection rate
• Rapid recovery • Adhesions & future PAS risk • Highest rupture risk
+-------------------------------------------------------------------------------------------------------------------+
Candidate Selection, Predictors & Contraindications
Careful candidate selection is the cornerstone of safe TOLAC management. Clinicians must evaluate prior surgical documentation and clinical history to stratify individual risk.
+-------------------------------------------------------------------------------------------------------------------+
| CANDIDACY SELECTION MATRIX FOR TOLAC / VBAC |
+-------------------------------------------------------------------------------------------------------------------+
CANDIDATE CATEGORY CLINICAL PROFILE & CRITERIA TOLAC ELIGIBILITY & SAFETY
--------------------- ------------------------------------------------------- -----------------------------------
IDEAL CANDIDATES • One prior Low-Transverse Cesarean Delivery (LTCD) • Highly Favorable
• Prior successful vaginal delivery (especially VBAC) • Success rate 70% to 90%
• Clinically adequate pelvis / Spontaneous labor onset • Uterine rupture risk ~0.5% to 0.9%
--------------------- ------------------------------------------------------- -----------------------------------
ACCEPTABLE • Two prior low-transverse cesarean deliveries • Acceptable candidates
CANDIDATES • Twin gestation (vertex/vertex at term) • Rupture risk ~0.9% to 1.8%
• Unknown prior scar type (unless high suspicion of • Requires informed consent and
classical incision, e.g., extreme preterm breech) experienced obstetric surgical team
• Mild fetal macrosomia (<4,500 g) without diabetes
--------------------- ------------------------------------------------------- -----------------------------------
ABSOLUTE • Prior CLASSICAL or T-SHAPED uterine incision • STRICTLY CONTRAINDICATED
CONTRAINDICATIONS • Prior extensive transmural uterine surgery • Catastrophic rupture risk (4% to 10%+)
(e.g., myomectomy entering the endometrial cavity) • Requires scheduled repeat cesarean
• Previous uterine rupture at 36 0/7 to 37 0/7 weeks
• Inability to perform emergent cesarean (no OR/anesthesia)
+-------------------------------------------------------------------------------------------------------------------+
Clinical Predictors of TOLAC Success vs. Failure
- Factors Significantly Increasing VBAC Success:
- Prior Vaginal Delivery: The single strongest clinical predictor of success. A patient with a prior successful vaginal delivery—especially a prior successful VBAC—has an expected success rate exceeding 85% to 90%, with a significantly reduced rate of uterine rupture.
- Non-Recurring Indication for Prior Cesarean: Indications such as breech presentation, twin gestation, non-reassuring fetal heart rate pattern, or placenta previa carry much higher success rates (>80%) compared to labor arrest.
- Spontaneous Labor Onset: Spontaneous labor onset without need for pharmacologic induction.
- Favorable Cervical Status: Advanced cervical dilatation and effacement (Bishop score >=8) upon admission.
- Factors Decreasing VBAC Success / Increasing Rupture Risk:
- Recurring Indication for Prior Cesarean: Labor dystocia, cephalopelvic disproportion (CPD), or active phase arrest during the previous pregnancy (success rate ~50% to 60%).
- Labor Induction / Augmentation: Need for cervical ripening or high-dose oxytocin titration.
- Maternal Demographics: Advanced maternal age (>=35 years), elevated pre-pregnancy BMI (>=30 to 40 kg/m²), and excessive gestational weight gain.
- Interdelivery Interval <18 to 24 Months: A short interval between deliveries limits complete myometrial extracellular matrix remodeling and tensile scar healing, doubling the baseline uterine rupture risk.
- Fetal Factors: Gestational age >40 weeks and estimated fetal weight >4,000 to 4,500 grams.
Intrapartum Management: Induction, Augmentation & Monitoring
Managing labor in a patient undergoing a TOLAC requires strict adherence to evidence-based safety protocols to maximize progress while safeguarding myometrial integrity.
+-------------------------------------------------------------------------------------------------------------------+
| TOLAC INTRAPARTUM MANAGEMENT PROTOCOL |
+-------------------------------------------------------------------------------------------------------------------+
[ 1. CERVICAL RIPENING PROTOCOL ]
• PROSTAGLANDINS (Misoprostol / PGE1 & Dinoprostone / PGE2) ARE STRICTLY CONTRAINDICATED.
- Prostaglandins induce hyperstimulation, collagen breakdown, and catastrophic scar disruption (rupture rate >2-3%).
• MECHANICAL METHODS ARE THE RIPENING MODALITY OF CHOICE:
- Transcervical Foley balloon catheter (30 to 60 mL sterile water inflation).
- Safe, effective, and does NOT increase uterine rupture risk.
[ 2. OXYTOCIN INDUCTION & AUGMENTATION ]
• May be used with caution; requires conservative, structured titration protocols.
• Avoid excessive dosing; strict avoidance of UTERINE TACHYSYSTOLE (>5 contractions in 10 minutes).
• Maintain low-to-moderate infusion rates to achieve adequate labor progress (200-250 MVUs) without hypertonus.
[ 3. CONTINUOUS ELECTRONIC FETAL MONITORING (EFM) ]
• Continuous EFM is MANDATORY from the onset of active labor / admission throughout delivery.
• Intermittent auscultation is STRICTLY INSUFFICIENT for TOLAC.
[ 4. REGIONAL NEURAXIAL ANALGESIA ]
• Epidural analgesia is SAFE and HIGHLY RECOMMENDED for TOLAC patients.
• Does NOT mask the signs of uterine rupture (breakthrough pain of rupture is severe visceral peritoneal pain
that penetrates effective epidural sensory block).
• Facilitates rapid conversion to surgical anesthesia if emergent laparotomy becomes necessary.
+-------------------------------------------------------------------------------------------------------------------+
Uterine Rupture: Pathophysiology, Clinical Manifestations & Emergency Management
Uterine rupture is the complete anatomical separation of all layers of the uterine wall (endometrium, myometrium, and overlying serosa/visceral peritoneum), frequently accompanied by extrusion of the fetus, umbilical cord, and placenta into the maternal peritoneal cavity.
+-------------------------------------------------------------------------------------------------------------------+
| UTERINE SCAR DEHISCENCE VS. TRUE UTERINE RUPTURE |
+-------------------------------------------------------------------------------------------------------------------+
FEATURE UTERINE SCAR DEHISCENCE (Uterine Window) TRUE UTERINE RUPTURE (Catastrophic)
---------------------- ----------------------------------------------- ------------------------------------------
Peritoneal Serosa INTACT (Visceral peritoneum intact over scar) DISRUPTED (Complete transmural separation)
Fetal Extrusion Absent (Fetus remains entirely intrauterine) Present (Fetus / placenta in peritoneum)
Hemorrhage Minimal to absent Massive intra-abdominal hemorrhage
Fetal Heart Rate Normal / Non-compromised Severe bradycardia / Prolonged decels
Clinical Action Incidental finding during cesarean; no repair EMERGENCY LAPAROTOMY / RESUSCITATION
+-------------------------------------------------------------------------------------------------------------------+
Clinical Manifestations of Uterine Rupture
+-------------------------------------------------------------------------------------------------------------------+
| CARDINAL CLINICAL SIGNS OF ACUTE UTERINE RUPTURE |
+-------------------------------------------------------------------------------------------------------------------+
1. ABNORMAL FETAL HEART RATE TRACING (The Earliest & Most Common Sign — Present in 70% to 90% of Cases)
• Sudden, severe, prolonged fetal bradycardia (<90-100 bpm) or recurrent, deep, late/variable decelerations
• Sudden loss of baseline FHR variability
2. SUDDEN CESSATION OF CONTRACTIONS / LOSS OF UTERINE RESTING TONE
• Uterine contractions abruptly stop or diminish in amplitude; IUPC records loss of baseline resting pressure
3. SEVERE, SUDDEN, UNREMITTING ABDOMINAL PAIN (Breakthrough Pain)
• Sharp, tearing, excruciating lower abdominal or suprapubic pain persisting between contractions
• Pain persists despite a fully functioning, dense epidural sensory block
4. LOSS OF FETAL STATION / REGRESSION OF THE PRESENTING PART
• Fetal presenting part that was deeply engaged (e.g., station +2) suddenly recedes and floats out of pelvis
5. PALPABLE FETAL PARTS ON ABDOMINAL EXAMINATION
• Fetal limbs or head easily palpated directly beneath maternal abdominal skin outside the contracted uterus
6. MATERNAL HEMODYNAMIC COLLAPSE & SHOCK
• Maternal hypotension, tachycardia, diaphoresis, pallor, syncope, and hemoperitoneum
• Vaginal bleeding may be present (variable; often minimal if blood accumulates entirely intra-abdominally)
+-------------------------------------------------------------------------------------------------------------------+
Emergency Nursing Interventions for Suspected Uterine Rupture
When acute uterine rupture is suspected, immediate interprofessional action is mandatory to prevent maternal-fetal mortality:
- Declare Obstetric Emergency: Call a STAT emergency code for immediate cesarean delivery. Alert the obstetrician, operating room scrub team, anesthesiologist, and Neonatal Resuscitation Program team.
- Discontinue Uterotonics: Immediately stop oxytocin infusions if running.
- Maternal Resuscitation & Oxygenation: Place patient in a lateral tilt position. Administer high-flow supplemental oxygen (10 L/min via non-rebreather mask).
- Aggressive Vascular Access & Volume Expansion: Ensure two large-bore IV lines (16- or 18-gauge). Rapidly infuse isotonic crystalloids (Lactated Ringer's) to support cardiac output.
- Blood Bank Mobilization: Activate the hospital Massive Transfusion Protocol (MTP) and obtain emergency uncrossmatched O-negative packed red blood cells or crossmatched units.
- Immediate Transfer to Surgical Suite: Rapidly transport the patient directly to the operating room for emergent exploratory laparotomy, fetal delivery, and surgical repair of the hysterotomy rupture or emergency peripartum hysterectomy.
A 29-year-old G2P1 at 39 weeks of gestation with one prior low-transverse cesarean delivery is admitted in spontaneous active labor for a Trial of Labor After Cesarean (TOLAC). Which of the following clinical factors in this patient's history is the strongest predictor of a successful Vaginal Birth After Cesarean (VBAC)?
A G2P1 patient at 40 weeks with one prior low-transverse cesarean delivery requires cervical ripening. Which cervical ripening agent or method is strictly contraindicated due to an unacceptably high risk of uterine rupture in patients with a scarred uterus?
An inpatient obstetric nurse is monitoring a patient undergoing a TOLAC who is at 8 cm dilatation. Suddenly, the fetal heart rate decelerates to 60 bpm and remains at 60 bpm for 3 minutes. The IUPC demonstrates an immediate cessation of uterine contractions, the patient complains of sudden sharp tearing abdominal pain unalleviated by her epidural, and the fetal vertex recedes from station +2 to station -2. What clinical condition should the nurse suspect immediately?
A patient with an effective labor epidural is undergoing a TOLAC. During a multidisciplinary briefing, a junior nurse asks if the epidural will obscure the clinical signs of uterine rupture. What is the most accurate clinical guidance regarding epidural analgesia during TOLAC?